• Assessment Of General Knowledge Concerning Health-Related Topics

    Nov 1, 2016, 00:00

  • Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis- A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population

    Nov 1, 2016, 00:00

  • External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

    Nov 1, 2016, 00:00

  • EQ-5D Utility Value Sets for Sri Lanka- A Case For Economic Evaluations in South Asia

    Nov 1, 2016, 00:00

  • Private and Catastrophic Health Expenditure of Patients with Early and Locally Advanced Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical Framework

    Nov 1, 2016, 00:00

  • Comparisons of Treatment Patterns for Type 2 Diabetes Mellitus (T2DMm) in Japan and in the United States

    Nov 1, 2016, 00:00

  • Comparison Of Biosimilar Guideline And Real Consumption Among Italian Regions

    Nov 1, 2016, 00:00

  • Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple Myeloma

    Nov 1, 2016, 00:00

  • A New Approach to Presenting Health States in Stated Preference Valuation Studies

    Nov 1, 2016, 00:00

  • The Management and Costs of Multiple Myeloma in Gree Mapping the Local Treatment Pathway and Associated Resource Use

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization (HCRU) in Relapsed/Refractory Multiple Myeloma (RRMM)- Comparison of EU and US Cohorts in the Preamble Study

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Amoxicillin-Clavulanic Acid in Csom Patients in a South Indian Hospital- A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy

    Nov 1, 2016, 00:00

  • Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal Outcomes

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Randomized Trials to Compare the Efficacy of Nsaids, Statins and Vitamins in Alzheimer's Disease

    Nov 1, 2016, 00:00

  • Development of An Alcohol Policy Model That Predicts Life Years, Qalys, and Health Care Costs Accounting for Alcohol use Disorder Identification Test

    Nov 1, 2016, 00:00

  • Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies

    Nov 1, 2016, 00:00

  • Assessing the Broader Economic Consequences of Hpv Prevention in Indonesia Using a Government Perspective Fiscal Analytic Method

    Nov 1, 2016, 00:00

  • Economic Impact Of Adverse Drug Reactions- A Pubmed Based Study

    Nov 1, 2016, 00:00

  • Impact of Diabetes Management on Diabetes Control and Resource Consumption in Type 2 Diabetic Patients

    Nov 1, 2016, 00:00

  • Costs of Care Between Resected and Non-Resected Pancreatic Cancer Patients- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Higher Weight, Higher Burden- Outcomes Of Adults In Japan With Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Temperature, Real Time, on Site, Potency Monitoring Studies of Different Brands of Cephalexin Tablets Stored in Hospital and Community Pharmacies in Different Part of Kerala

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Improving Adherence to Diabetes Treatment In Patients with Type 2 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Omalizumab for the Treatment of Chronic Spontaneous Urticaria in France

    Nov 1, 2016, 00:00

  • Not All Cochrane Reviews Are Good Quality Systematic Reviews

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • European Comparison of Spinal Surgery Hospitalizations From 2010 to 2013 According to Patient Profiles

    Nov 1, 2016, 00:00

  • Cancer Immunotherapy with Checkpoint Inhibitors is Associated with Immune-Mediated Reactions- A Pharmacovigilance Study

    Nov 1, 2016, 00:00

  • Household Cost Of Injuries in Children Under Five Years in the Ejisu-Juabeng Municipality of the Ashanti Region, Ghana- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Effects Of Pharmacist Counseling on Outpatients Receiving Warfarin at Dr. Hasan Sadikin Bandung Hospital

    Nov 1, 2016, 00:00

  • Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Managed Entry Agreements- Portuguese Experience

    Nov 1, 2016, 00:00

  • Discharge Prescription Patterns of Antipsychotics In Patients With Mental Illness Hospitalized Compulsorily By Prefectural Governors

    Nov 1, 2016, 00:00

  • HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain)- Pilot Study Focused in Orphan Drugs

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy

    Nov 1, 2016, 00:00

  • Ict Diffusion and Pharmaceuticals (Issues For Decision Tools)

    Nov 1, 2016, 00:00

  • Determining Criteria and Weights for Prioritising Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Nov 1, 2016, 00:00

  • Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism

    Nov 1, 2016, 00:00

  • Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Germany Based on Sick Fund Data Analysis

    Nov 1, 2016, 00:00

  • Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and Therapy

    Nov 1, 2016, 00:00

  • Prescription Patterns And Costs Of Migraine Therapy In Germany

    Nov 1, 2016, 00:00

  • Do We Really Know when We Should Screen for Hepatitis B C before Starting Immunosuppressive Therapy ?

    Nov 1, 2016, 00:00

  • Risk Elements and Drug Utilization in Stroke Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Everolimus or Axitinib in Patients with Metastatic Renal Cell Carcinoma WHO Have Failed to Use of Pazopanib or Sunitinib in First-Line Treatment

    Nov 1, 2016, 00:00

  • Adherance To Medication Errors Repoting System At Public Hospital, Riyadh, Saudi Arabia

    Nov 1, 2016, 00:00

  • Setting Recommendations for Good Practice of Health Technology Assessment in the Egyptian Ministry of Health

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Bevacizumab Compared to Cetuximab and Panitumumab in First-Line Treatment of Kras Wild-Type Metastatic Colorectal Cancer in France

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- Past, Present and Future

    Nov 1, 2016, 00:00

  • Geographic, Racial, and Temporal Variations of Adherence to Screening for Cervical Cancer and HPV Vaccination in The United States, 2008-2012

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis- A Comparison Between Preset Artery Blood Samplers and Disposable Syringes in Arterial Blood Sampling

    Nov 1, 2016, 00:00

  • Improving Access to Psychological Therapies in British Sign Language (BSL)- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Specialty Pharmacy, Diagnostic, And Genetic Testing Coverage In The United States

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • Work Productivity Activity Impairment Loss of Patients with HER2 Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Direct Cost Of Hiv/Aids In Turkey

    Nov 1, 2016, 00:00

  • Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • In-Hospital Mortality and Complications Following Surgical Resection of Glioblastoma

    Nov 1, 2016, 00:00

  • Personalized Mammography Screening and Screening Adherence - A Simulation of Cost-Effectiveness

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Tips Procedures with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Large Volume Paracentesis in Patients with Refractory Ascites – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment Switching

    Nov 1, 2016, 00:00

  • Policy Evaluation on“The Pay-For-Performance Program of Hepatitis B and C” in Taiwan

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Parallel Export And Its Impact On Availability Of Drugs In Slovakia

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Indonesian Asthma Patients

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • Nothing Ventured, Nothing Gained – Is The Innovation Fund The Catapult to A New Generation of Care Concepts and A Competitive Market in Health Care in Germany?

    Nov 1, 2016, 00:00

  • A Unique Opportunity To Assess Quality-Of-Life Changes In Long-Term Waitlisted Bariatric Surgery Patients Using The Eq-5d-5l And Aqol-8d Multi-Attribute Utility Instruments Before And Three Months After Bariatric Surgery- An Exploratory Stu ...

    Nov 1, 2016, 00:00

  • Validation Of Comorbidity Indices (Charlson And Elixhauser) Computed In Cross Sectional Hospital Billing Data

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • The First Indonesian Health-Related Quality of Life Valuation Study- An Eq-5d-5l Value Set

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Market Uptake Of Pharmaceutical Innovations In Germany - Regulatory Approaches And Its Consequences

    Nov 1, 2016, 00:00

  • General Public Knowledge and Awareness About Medicines Use in Penang, Malaysia

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Changing Patterns of Medication Use at the End of Life in the Elderly

    Nov 1, 2016, 00:00

  • Analysis on the Regional Distribution of Telemedicine in China

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00

  • Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models- A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 Study

    Nov 1, 2016, 00:00

  • Direct Economic Burden in Patients with Cerebral Venous Thrombosis at A Tertiary Care Hospital in South India

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • Incremental Cost-Effectiveness of Algorithm-Driven Genetic Testing Versus no Testing for Maturity Onset Diabetes of the Young (Mody) in Singapore

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Lower Extremity Functional Scale Among Foot And Ankle Patients

    Nov 1, 2016, 00:00

  • An Observational Study on Risk Factors and Clinical Presentation S In Stroke Patients

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Assessing The Clinical And Economic Burden of Prostate Cancer in The United States Veteran Population

    Nov 1, 2016, 00:00

  • Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

    Nov 1, 2016, 00:00

  • Clinical Impact of Antimicrobial Impregnated Catheters For Reduction of Infection In Cerebrospinal Fluid Diversion Procedures

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Treatment Rates in Patients with HER2+ Metastatic Breast Cancer and the Factors Influencing Treatment Decision

    Nov 1, 2016, 00:00

  • The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • Different Methods, Different Results? Comparing Health Technology Assessments in the United Kingdom and Germany

    Nov 1, 2016, 00:00

  • Assessing Health-State Utility Values in Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas

    Nov 1, 2016, 00:00

  • A Risk-Benefit Analysis of Key Performance-Based Risk Sharing Agreements (PBRSAS) in the EU and US (2002-2016)

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Added Benefit of Upper Airway Stimulation For The Treatment of Moderate To Severe Obstructive Sleep Apnea In Austria

    Nov 1, 2016, 00:00

  • The Evolution And Comparison Of Hta Assesment Organisations In Selected European Countries

    Nov 1, 2016, 00:00

  • The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Investigating The Economic Impact of Sflt-1/PLGF Ratio As A Predictive Test in Women with Suspected Preeclampsia in Italy

    Nov 1, 2016, 00:00

  • Using Acoustic Simulations of Hearing Loss to Describe Health States- Are they Feasible and Reliable to use?

    Nov 1, 2016, 00:00

  • The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online Data

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • The Role of Insulin-Like Growth Factor-1 on Steatohepatitis

    Nov 1, 2016, 00:00

  • The Patient-Risk of Hypoglycaemia As A Function of Pharmacological Treatments. A Retrospective Analysis on Database Hypothesis

    Nov 1, 2016, 00:00

  • Literature Review on Hospital Costs for Patients Undergoing Gastrectomy

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China

    Nov 1, 2016, 00:00

  • Economic and Humanistic Impact Assumptions for Hypoglycemic Events- Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes

    Nov 1, 2016, 00:00

  • Bio-Similar Or Different? – Understanding The Payer Perspective

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

    Nov 1, 2016, 00:00

  • UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy

    Nov 1, 2016, 00:00

  • The Outcomes of A Pharmaceutical Care Assistance Program in A Romanian Community Pharmacy

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In Brazil

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • Comparison of Three Generic Utility Instruments In Patients With Renal Disease

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • PCSK9-Inhibitors- Identification of Eligible Patients from Regional Administrative Healthcare Databases

    Nov 1, 2016, 00:00

  • Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • Racial Disparities In Access To Pharmacy And Its Services In Pennsylvania

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to ...

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • The Increasing Role of Wearable Digital Technology in Disease Management - An Assessment of the Opportunities and Challenges from a Multi-Stakeholder (Patient, Payer, Physician, Manufacturer) Perspective

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • Approach to Implementation of a Feasible Antibiotic Stewardship Program at a Tertiary University Public Hospital

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los And Costs) of Adhesion Related Complications after Liver Resection Surgery

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Ranibizumab And Aflibercept For Central RVO- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Drug Utilization Study of Antibiotics in A Secondary Care Referral Hospital

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Colorectal Cancer in Slovak Republic

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Nov 1, 2016, 00:00

  • Challenges for HTA Submissions Concerning Conditions Lacking Established Treatment Pathways

    Nov 1, 2016, 00:00

  • Single-Arm Trials in Systematic Reviews- Are They Adequately Captured by Existing Search Filters?

    Nov 1, 2016, 00:00

  • The Relationship Between Target Joints And Non-Drug Direct Costs In Severe Haemophilia

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Viacoram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Early Benefit Assessment Of Drugs And The Value-Based Healthcare Concept – A Qualitative Inquiry Within The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • Combined use of Administrative Data Flows with Innovative Biologic Drug Registries to Assess Therapeutic Appropriateness- An Italian Regional Experience

    Nov 1, 2016, 00:00

  • A 12-Week Cost Analysis to Compare Fluticasone Furoate/Vilanterol And Beclomethasone Dipropionate/Formoterol In The Treatment of Mild-To-Moderate Asthma

    Nov 1, 2016, 00:00

  • Pharmaceutical Pricing Strategies In Developing Countries- A Systematic Review

    Nov 1, 2016, 00:00

  • Movement of Drugs for Cancer Through The Pharmacoeconomic Evaluation Process in Ireland- Consideration Given to The Quality of Clinical Evidence

    Nov 1, 2016, 00:00

  • Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System

    Nov 1, 2016, 00:00

  • Analysis of Hta Requirements Across 10 Emerging and Developed Countries

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Scores in Breast Cancer Survivor Women with and without Breast Reconstruction Surgery

    Nov 1, 2016, 00:00

  • Evaluating Effectiveness And Persistency of A Pharmacist-Led Disease Management Program

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dabigatran for The Prevention of Stroke in Iranian Atrial Fibrillation Patients

    Nov 1, 2016, 00:00

  • Management and Outcomes of Acute Kidney Injury

    Nov 1, 2016, 00:00

  • Deep Brain Stimulation Compared to Device-Aided Infusion Therapies for Parkinson’s Disease with Early Motor Complications- A UK Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates- Comparison of Results from a Clinician Survey

    Nov 1, 2016, 00:00

  • Estimating the Value of Treatment for Fabry Disease- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Health Assessment Questionnaire (Haq) in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • Breast Cancer in China- Room for Improved Screening

    Nov 1, 2016, 00:00

  • Study Care Costs and Use of Health Technologies for Patients with Hemophilia a Health System Affiliates in Colombia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treatment of Previously Treated PD-l1 Positive Advanced NSCLC Patients

    Nov 1, 2016, 00:00

  • Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age

    Nov 1, 2016, 00:00

  • Is the Orphanage Filling Up? Projecting the Growth and Budget Impact of Orphan Drugs in Europe

    Nov 1, 2016, 00:00

  • Reliability and Convergent Validity of The Nei Vfq-25 with and Without Near and Distance Activity Appendix Items In Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

    Nov 1, 2016, 00:00

  • Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma

    Nov 1, 2016, 00:00

  • Is There a Justification to Fullfill the Gap in Clinical Pathway of Inflammation and Itching Treatment in Poland - Cost-Utility Analysis (CUA) of Mometasone Furoate Ointment

    Nov 1, 2016, 00:00

  • Comparison Of The Relationship Between Socio-Economic Status And Health-Related Quality Of Life Amongst Atopic Dermatitis Patients Across Different Healthcare Systems

    Nov 1, 2016, 00:00

  • Role Of Tuberculosis Home Observer In Improving Clinical Outcome Of Patient In Yemen

    Nov 1, 2016, 00:00

  • Comparision Of Perception Towrds Generic Medicines Between Final Year Pharmacy And Medical Students In Southeast Yemen

    Nov 1, 2016, 00:00

  • The Short-Term Health and Economic Burden of Gestational Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Adoption of Transcatheter Mitral Valve Repair in Germany- Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014

    Nov 1, 2016, 00:00

  • Economic Burden of Advanced Gastric Cancer (AGC) in Mexico

    Nov 1, 2016, 00:00

  • Development of the Musculoskeletal Health Questionnaire (MSK-HQ) for Use in Different Conditions and Different Healthcare Pathways

    Nov 1, 2016, 00:00

  • A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2016, 00:00

  • New Data on the Burden of Abnormal Pap Smears and Hospitalised Pre-Cancerous Lesions in France (EGB AND PMSI DATABASES ANALYSIS)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In Greece

    Nov 1, 2016, 00:00

  • Treatment Switching Problem in Cancer Clinical Trials – Implications for Health Technology Appraisal Outcomes

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile

    Nov 1, 2016, 00:00

  • For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia

    Nov 1, 2016, 00:00

  • Critical issues influencing cost-effectiveness analyses of pneumococcal vaccine strategy for elderly in japan

    Nov 1, 2016, 00:00

  • Clinical Effectiveness Telepsychotherapy for Depression Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Success and Failure of Straightforward Versus Sophisticated Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Trend Of Antidepressant Utilization In Iran, 2006- 2015

    Nov 1, 2016, 00:00

  • Real Life Drug Utilization and Biologics Effectiveness in Patients With Crohn's Disease – A Population-Based Study in Taiwan

    Nov 1, 2016, 00:00

  • Pessoa Study – Evaluating The Burden of Psoriasis In Portugal From The Patients’ Perspective (A Patient Reported Outcomes Analysis)

    Nov 1, 2016, 00:00

  • Protective Effect of Metformin Against Tuberculosis in Diabetic Patients

    Nov 1, 2016, 00:00

  • Relations between Adherence to Therapy and Quality of Life (Qol) In Cml Patients in Bulgaria

    Nov 1, 2016, 00:00

  • The Invariance Analysis Of Sf12v2- ¿Are Comparable The Quality Of Life Results Of Men And Women?

    Nov 1, 2016, 00:00

  • Meta-Analysis of Newer Anti-Epileptic Drugs for Treatment of Partial Epilepsy in Children

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer In Croatia - Cost of Disease Study

    Nov 1, 2016, 00:00

  • A Study Evaluating Living Organ Donors In Kidney And Liver Transplantation

    Nov 1, 2016, 00:00

  • Evaluation of Supportive Care in the Cancer Patients on Chemotherapy in a Developing Country- A Comparision of Clinical Practice with Standard Guidelines

    Nov 1, 2016, 00:00

  • The Effects of Continues Glucose Monitoring System on Patient Outcomes and Associated Costs

    Nov 1, 2016, 00:00

  • Reimbursement of Insulin for Diabetes- Implementation from the Ukrainian Health Care Perspective

    Nov 1, 2016, 00:00

  • Developing Item Pools for Physical Functioning, Social Relationships, and Positive Mindset to Measure Health-Related Quality of Life (HRQOL) in the Singapore Population

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spond ...

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Capsule and Injectable Etoposide To The Treatment of Osteosarcoma

    Nov 1, 2016, 00:00

  • The Frequency of Relapsed or Refractory Disease After Autologous Stem Cell Transplantation in Classical Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2016, 00:00

  • A Systematic Review on the Evidence of Adequate Discount Rates for Vaccines in Germany

    Nov 1, 2016, 00:00

  • Cancer Associated Medical Spending- US National Data Between 2000 and 2013

    Nov 1, 2016, 00:00

  • Measuring the Relationship between Hospital Costs and Quality of Care- An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Utility In Idiopathic Pulmonary Fibrosis In France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Saxagliptin Versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tocilizumab Vs Abatacept In Methotrexate-Experienced Patients with Rheumatoid Arthritis In Italy

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis For The Treatment Of Primary Immunodeficiency Disease (Pidd) In The Mexican Social Security Institute In 2016

    Nov 1, 2016, 00:00

  • The Impact Of Increasing Disability On Employment And Caregiver Burden Among Multiple Sclerosis Patients In Brazil

    Nov 1, 2016, 00:00

  • The Cost of Post Stroke Treatment at Selected Public Primary Care Healthcentres In Malaysia

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in Italy- A Probabilistic Cost of Illness Analysis

    Nov 1, 2016, 00:00

  • Exercise and Factors Influence Mental Health Of Undergraduated Students At Burapha University In 2014

    Nov 1, 2016, 00:00

  • Patient-Relevant Endpoints In Psoriasis – A Literature Review Of Patient Preference Studies

    Nov 1, 2016, 00:00

  • Should Patients Estimate Health Related Quality Of Life? The Results Of Empirical Study

    Nov 1, 2016, 00:00

  • Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial

    Nov 1, 2016, 00:00

  • Dice Simulation- A New Method that Facilitates Decision-Analytic Modeling

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

    Nov 1, 2016, 00:00

  • Relapse Rates and Healthcare Resource use of Therapy Persistent And Non-Persistent Multiple Sclerosis Patients In Germany – A Real World Analysis

    Nov 1, 2016, 00:00

  • Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain

    Nov 1, 2016, 00:00

  • A Systematic Review Of Economic Evaluation Alongside Hematopoietic Stem Cell Transplantation In Japan

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted by Absenteeism Associated with Insulin Dependent Diabetes Mellitus (IDDM) in Poland

    Nov 1, 2016, 00:00

  • Prices And Affordability Of Reimbursed Pharmaceuticals- A European Cross-Country Study

    Nov 1, 2016, 00:00

  • A First Cost-Effectiveness Analysis Based on Real Life Clinical Outcomes of Bevacizumab+ Paclitaxel Compared to Paclitaxel Among French Patients with HER2- Metastatic Breast Cancer in First Line of Treatment

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany

    Nov 1, 2016, 00:00

  • Understanding The Role of Dermatologists And Oncologists In Melanoma Treatment In France and The UK

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan- Comparison of Results From A Clinician Survey

    Nov 1, 2016, 00:00

  • Implications of Total Budget Impact on Oncology Drug Pricing in The us And EU5

    Nov 1, 2016, 00:00

  • Public Consultation as a Tool for Patient and Public Involvement in The Brazilian HTA Process

    Nov 1, 2016, 00:00

  • 5 Year and Long-Term Budget Impact Analysis of New Hepatitis C Therapies from A Payer Perspective in Switzerland

    Nov 1, 2016, 00:00

  • Attributes Defining Patient Engagement And Centeredness In Health Care Research And Practi A Framework Developed By The Ispor Patient-Centered Special Interest Group

    Nov 1, 2016, 00:00

  • Pharmaceutical Reimbursement Of Innovative Medicinal Products In Belgium

    Nov 1, 2016, 00:00

  • Intravenous (IV) Admnistration of Morphine For Moderate-To-Severe Acute Pain In The Emergency Room (ER) Setting Inflicts A Substantial Economic Burden In The EU5

    Nov 1, 2016, 00:00

  • Acute Cardiovascular Adverse Reaction of Cox-2 Inhibitors Among Osteroarthritis Patients in Taiwan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Three Regions In Italy

    Nov 1, 2016, 00:00

  • Prevalence, Potential Risk Factors, Sequelae of Diastasis Recti Abdominis and The Treatment

    Nov 1, 2016, 00:00

  • Effect Of Sociodemographic Determinants And Socio-Economic Status On Poliomyelitis Immunization Among Under-Five Children In Pakistan

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns Among Patients with Ovarian Cancer- An Analysis of a Large us Electronic Health Records Database

    Nov 1, 2016, 00:00

  • Legislative Framework for Reimbursement Conditions for Gene Therapies

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Reduced Ejection Fraction (HF-REF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Stroke- An Analysis in Ho Chi Minh City 115 People's Hospital, Vietnam

    Nov 1, 2016, 00:00

  • Accuracy Of Text Processing Tokenisers For Automated Identification Of Diseases And Interventions In Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • Quality of Life in Advanced Melanoma- Results of The Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications on Smoking Cessation and Relapses Among Elderly Smokers

    Nov 1, 2016, 00:00

  • What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungary

    Nov 1, 2016, 00:00

  • Adherence to Drug-Related Monitoring Guidelines for Multiple Sclerosis Therapies- Real-World Evidence From A Us Claims Database

    Nov 1, 2016, 00:00

  • Cost Analysis Of Comorbities- Evidence From A Hiv+ Patients Cohort

    Nov 1, 2016, 00:00

  • Burden of Disease And Management of Mesothelioma In Fran A National Cohort Analysis

    Nov 1, 2016, 00:00

  • Impact of State Mandated Queries of The Prescription Drug Monitoring Programs on Opioid And Non-Opioid Drug Related Adverse Effects- A Difference In Difference Approach

    Nov 1, 2016, 00:00

  • Budget Impact Model to Augment The Value of An Innovative Device for The Early Detection of Pressure Ulcers in Scotland

    Nov 1, 2016, 00:00

  • Drug Utilizaton and Pharmacoeconomic Analysis of Geriatric Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • A Real Concern Or Just A Hype? – Evidence On Negative Clinical Consequences Of Switching From Originator To Biosimilar Based On A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Post-Stroke- An Analysis in Hospital of Occupational Diseases and Rehabilitation, Vietnam

    Nov 1, 2016, 00:00

  • Real World use of Biologics Therpies for Patients with Ulcerative Colitis in Japan

    Nov 1, 2016, 00:00

  • A Comparison Of Health State Utilities Among Breast Cancer Patients In Mainland China

    Nov 1, 2016, 00:00

  • Subatmospheric Pressure Therapy Efficiency for the Treatment of Pressure Ulcers- A Health Techonology Assessment

    Nov 1, 2016, 00:00

  • Concordance of Health Technology Assessment Recommendations of Diabetes, Hepatitis, Oncology and Epilepsy Pharmaceutical Products by Five Agencies within Europe- An Interrater Reliability and Association Analysis

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge, Attitude And Practice (Kap) Of Pharmacist Regarding Adverse Drug Reaction (Adrs) And Pharmacovigilance In Public Hospitals Quetta

    Nov 1, 2016, 00:00

  • Assessment of Awareness and Knowledge of Breast Cancer in Pakistani Females; A Quantitative Study

    Nov 1, 2016, 00:00

  • Special Considerations and Patient Access Schemes for Oncology by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in The Guangdong Healthcare Setting in China

    Nov 1, 2016, 00:00

  • A Health Policy Study Measuring The Gap Analysis Between The Management of Metastatic Conditions and Other Diseases Under The Egyptian Healthcare Insurance System

    Nov 1, 2016, 00:00

  • A Review of Studies of Health-Related Quality of Life Performed in Chinese-Speaking Ischemic Heart Disease Patients

    Nov 1, 2016, 00:00

  • Association Between Orphan Drug Prices and Therapeutic Area

    Nov 1, 2016, 00:00

  • Treatment Persistence and Discontinuation Risk of Typical Depot and Atypical Long-Acting Antipsychotics in Patients with Schizophrenia in Poland

    Nov 1, 2016, 00:00

  • Eliciting Individual Patient Preferences on The Benefits and Risks of Cancer Treatments- Results From A Survey Conducted in Myeloma Patients

    Nov 1, 2016, 00:00

  • Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China

    Nov 1, 2016, 00:00

  • Differential Patterns of Persistent Opioid Use in Patients with Cancer and Non-Cancer Pain

    Nov 1, 2016, 00:00

  • Prospective Utility Study of Patients with Multiple Cardiovascular Events

    Nov 1, 2016, 00:00

  • Risk Factors of Cardiovascular Disease in Malaysian Diabetes Patients

    Nov 1, 2016, 00:00

  • Cancer Prevention- Knowledge And Attitudes Among Healthcare Professionals

    Nov 1, 2016, 00:00

  • Further Validation of the Haemopref in a Real-World Setting

    Nov 1, 2016, 00:00

  • Development of Hta In Kazakhstan

    Nov 1, 2016, 00:00

  • Novel Oral Anticoagulants in the UK and Fran Comparative Assessment of Costs of Prescriptions Dispensed in the Non-Hospital Setting

    Nov 1, 2016, 00:00

  • Insights from 6 Years' Managed Entry Agreement Experience in Belgium

    Nov 1, 2016, 00:00

  • Policy Objective of Generic Medicines from the Investment Perspective- The Case of Clopidogrel

    Nov 1, 2016, 00:00

  • To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Measurement Properties of The EQ-5D-5l Compared To The EQ-5D-3L In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Venous Thromboembolism (VTE) Among Hospitalized Patients in China- An Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Review of Economic Evaluation of Saxagliptin in Type2 Diabetes in China

    Nov 1, 2016, 00:00

  • The Ethical Issues Of Pharmacogenetic Tests

    Nov 1, 2016, 00:00

  • Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D

    Nov 1, 2016, 00:00

  • Colorectal Cancer Treatment Costs in Estonia

    Nov 1, 2016, 00:00

  • The Choice Between HIP Prosthetic Implants in Total HIP Replacement- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Clinical Outcomes of Bipolar Disorder on Long-Term Treatment with Lithium with or without Mood Stabilizers

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Olaparib Use in Patients Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • CARDIOVASCULAR DISORDERS - Patient-Reported Outcomes Patient Preference StudiesTreatment Patterns and Medication Adherence of Acute Ischemic Stroke Patient in Korea

    Nov 1, 2016, 00:00

  • The Association Between Parenting Stress And The Child’s Quality of Life Among Parents of Asthmatic Children

    Nov 1, 2016, 00:00

  • Eliciting Payers Preferences In Central And Eastern Europe- Results Of Mcda Case Study

    Nov 1, 2016, 00:00

  • Nine Tests For Assesing Validity Of A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Quality of Life for Patients Using Hemodialysis (HD) vs. Peritoneal Dialysis (PD) Modalities in Taiwan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Certolizumab Pegol In Adults With Axial Spondyloarthritis In Mexico

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis on Tolerability and Efficacy of Sofosbuvir Containing Regimens in Hepatitis C Patients With Stage 4-5 Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal

    Nov 1, 2016, 00:00

  • What Happens To Originator Medicines When (Generic) Followers Enter The Public Market

    Nov 1, 2016, 00:00

  • Developing and Testing A Stated-Preference Instrument to Prioritize Treatment Goals Among Patients with Recent Onset Schizophrenia

    Nov 1, 2016, 00:00

  • The Sale of Antibiotics Without Prescription In Retail Pharmacies- A Cross-Sectional Survey In Three Cities of China

    Nov 1, 2016, 00:00

  • Equity of Government Subsidy in Health Care- A Case Study in China

    Nov 1, 2016, 00:00

  • Patient Reported Health Utility in HR+/HER2- Advanced/Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Medication Reconciliation- A Tool for Better Patient Care

    Nov 1, 2016, 00:00

  • Evaluation of Injectable Lanreotide Acetate in The Treatment of Liver Carcinoma

    Nov 1, 2016, 00:00

  • Adapting Data Sources for Systematic Literature Review Retrieves Additional Data Relevant for Asian HTA

    Nov 1, 2016, 00:00

  • A Retrospective Observational Cohort Study To Investigate Treatment Outcome of Mrsa Patients Administrated with Anti-Mrsa Drugs using Large Insurance Claims Data in Japan

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cementless Versus Cemented Prostheses for Total HIP Arthroplasty From A UK Hospital Perspective

    Nov 1, 2016, 00:00

  • Recent Trends In Different Devices, Operating Systems, And Browsers Used By Patients Taking Part In Online Medical Surveys

    Nov 1, 2016, 00:00

  • Beyond Cervical Cancer- The Cost-Effectiveness Of Hpv Vaccination In The Netherlands

    Nov 1, 2016, 00:00

  • Measuring Treatment Satisfaction and Preference in Patients with Asthma and Copd- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Access to Anti-Cancer Drugs In India- Is There a Need to Revise Reimbursement Policies?

    Nov 1, 2016, 00:00

  • Comparative Safety and Effectiveness of Telemonitoring Intervention Versus Usual Care for Heart Failure- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Project Octo-Pills- Management Of Polypharmacy And Drug Related Problems From Hospital To Community Pharmacies – An Octopus Initiative For The Silver Tsunami

    Nov 1, 2016, 00:00

  • Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as Outcome

    Nov 1, 2016, 00:00

  • patient Characteristics and Treatment Patterns of Venous Thromboembolism (Vte) Among Hospitalized Patients in China- an Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

    Nov 1, 2016, 00:00

  • Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results

    Nov 1, 2016, 00:00

  • Irrational Use of Antibiotics in Turkey

    Nov 1, 2016, 00:00

  • The Probabilistic Efficiency Frontier- A Value Assessment Of Treatment Options In Hepatitis C

    Nov 1, 2016, 00:00

  • Baseline Characteristics and Survival of Patients Diagnosed with Advanced NSCLC in Sweden Between 2006 and 2013, Matched (1-4) To A Comparison Cohort From The General Population

    Nov 1, 2016, 00:00

  • Patient Reported Asthma Control In Comparison To Physician Assessed Asthma Control- A Cross-Sectional Analysis of The Act Questionnaire Based on 673 Asthma Patients

    Nov 1, 2016, 00:00

  • The Role of Budget Impact on HTA Rejection of Oncology Drugs in Romania

    Nov 1, 2016, 00:00

  • Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma

    Nov 1, 2016, 00:00

  • Cost of Treatment Hypertention Inpatients in Vietnam

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

    Nov 1, 2016, 00:00

  • Economic Value of Eptfe Stent-Grafts Compared to Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in England

    Nov 1, 2016, 00:00

  • Insights for Care- Comparison of Healthcare Utilisation and Cost Impact of Managing Diabetes Patients with Hypoglycaemia to Patients with Heart Failure or Stroke Using Real-World Evidence Data from an Urban Healthcare System in Birmingham, ...

    Nov 1, 2016, 00:00

  • Preferences For Treatment Attributes Of Dulaglutide And Liraglutide Among Patients With Type 2 Diabetes Mellitus And Their Willingness To Self-Inject Diabetes Medication- A Comparison Between Japan And The United Kingdom

    Nov 1, 2016, 00:00

  • A Comparison of National Guidelines for Network Meta Analysis

    Nov 1, 2016, 00:00

  • Treatment Pattern of Antibiotics and Cost Analysis in Sepsis Patients- A Cross Sectional Retrospective Prospective Study

    Nov 1, 2016, 00:00

  • Application of Healthcare Failure Mode Effect Analysis in Improving Patient Education at an Outpatient Department af a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • A New Model to Identify Multivariate Causes of High Cost in Patient With Advanced Liver Disease

    Nov 1, 2016, 00:00

  • Validity Of The Eq-5d-Youth In Asthmatic Children

    Nov 1, 2016, 00:00

  • The Prevalence of Atypical Antipsychotic Medication Use For Pediatric Psychosis in Korea

    Nov 1, 2016, 00:00

  • European Regulators and Payers Initiatives for Drug Access- Collaborations or Divergences?

    Nov 1, 2016, 00:00

  • Psychometric Evaluation of Clinical Outcomes Assessments in A Phase II Trial

    Nov 1, 2016, 00:00

  • A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers

    Nov 1, 2016, 00:00

  • France-Spain Comparison of Hospital Delivery Mode Between 2006 And 2014 According Comorbidity Profiles of Patients

    Nov 1, 2016, 00:00

  • Evaluation of Antibacterial and Cytotoxic Effects of Gymnema Sylvestre R.BR. Species Cultivated in Pakistan Against Common Resistant Pathogens

    Nov 1, 2016, 00:00

  • Overview of the Budget Impact Analysis of Drugs in Hungary and Internationally

    Nov 1, 2016, 00:00

  • Table of Contents

    Nov 1, 2016, 00:00

  • Modelling The Economic Impact of Implementing Treatment-Free Remission (TFR) In Philadelphia+ (PH+) Chronic Myelogenous Leukemia In Chronic Phase (CML-CP) Patients Treated In First Line (1l) With The Tyrosine Kinase Inhibitors (TKI)- Imatin ...

    Nov 1, 2016, 00:00

  • Trading-Off Quality of Life and Survival Time – Feasibility of Web-Based Discrete Choice Experiments For QLU-C10D Utility Elicitation in Cancer Patients

    Nov 1, 2016, 00:00

  • Dexhelpp - Aging Population- Routine Data Based Analyses Of Fractures Due To Falls Less Than Three Meters – Hospitalization, Readmission And Mortality

    Nov 1, 2016, 00:00

  • "Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of Coas

    Nov 1, 2016, 00:00

  • The Adoption Trends of Robotic-Assisted Benign Hysterectomy in United States From 2008 to 2014

    Nov 1, 2016, 00:00

  • Pegaspargase Versus Asparaginase In Childhood Acute Lymphoblastic Leukemia- A Cost-Minimization Analysis In France

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor for The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Avoidable Hospitalizations Through Effective Primary Care At A Pediatric Hospital In The Colombian Caribbean

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Modified Mobility Section Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal

    Nov 1, 2016, 00:00

  • Opportunities For Pharmaceutical Companies To Successfully Launch Products In African Countries

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis on Hepatic Carcinoma Patients with Hepatitis C

    Nov 1, 2016, 00:00

  • An Economic Model of Advance Care Planning- A Cost Effective Intervention for People with Dementia

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • A Study on Evaluation of Effects of Anti-Tubercular Drugs on Hematological and Hepato-Renal Functions in Tuberculosis Patients

    Nov 1, 2016, 00:00

  • Assessment of Community Pharmacy Services in Malaysia- Perspectives from Community Pharmacists, General Practitioners, Consumers and Health Policy Stakeholders

    Nov 1, 2016, 00:00

  • Generic drugs- do they offer the same safety and efficacy as originator medicines? -perceptions and attitudes of final year pharmacy students in greece

    Nov 1, 2016, 00:00

  • Hba1c Variability Predicts Short-Term Risk of Albuminuria In Patients with Type 2 Diabetes

    Nov 1, 2016, 00:00

  • EU5 Patient's Willingness to Try New Techniques for Managing their Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Biosimilars In A Belgian Tertiary Care Hospital- A Simulation

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile

    Nov 1, 2016, 00:00

  • Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population Sizes

    Nov 1, 2016, 00:00

  • Ebola Virus Disease and Its Management- A Review

    Nov 1, 2016, 00:00

  • The Economic Value of Rapid Deployment Aortic Valve Replacement Via Full Sternotomy

    Nov 1, 2016, 00:00

  • Costs Evolution Of Cancer Therapies In Europe From 2004 To 2014

    Nov 1, 2016, 00:00

  • Cost Analysis of Intrathecal Baclofen Therapy For The Treatment of Spastic Cerebral Palsy In The Russian Federation

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol Use and Indications in the Netherlands

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Amritha Guggulu in the Management of Gout

    Nov 1, 2016, 00:00

  • A Cost Effectiveness Analysis of Rosuvastatin Against Atorvastatin in Cardiovascular Diseases and Stroke- An Ambispective Study

    Nov 1, 2016, 00:00

  • An Investigation Into Open-Source Modelling In Health Economics- Opportunities And Challenges

    Nov 1, 2016, 00:00
  • «
  • 81 (current)
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »